SE429481B - Sett att pavisa hepatit-b-ytantigen genom latexagglutination - Google Patents

Sett att pavisa hepatit-b-ytantigen genom latexagglutination

Info

Publication number
SE429481B
SE429481B SE7600797A SE7600797A SE429481B SE 429481 B SE429481 B SE 429481B SE 7600797 A SE7600797 A SE 7600797A SE 7600797 A SE7600797 A SE 7600797A SE 429481 B SE429481 B SE 429481B
Authority
SE
Sweden
Prior art keywords
pavisa
latexagglutination
hepatit
pavisa hepatit
Prior art date
Application number
SE7600797A
Other languages
English (en)
Other versions
SE7600797L (sv
Inventor
G E Lowke
B Z Horvath
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SE7600797L publication Critical patent/SE7600797L/sv
Publication of SE429481B publication Critical patent/SE429481B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/816—Attached to the carrier via a bridging agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7600797A 1975-02-19 1976-01-26 Sett att pavisa hepatit-b-ytantigen genom latexagglutination SE429481B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/550,949 US3992517A (en) 1975-02-19 1975-02-19 Detection of hepatitis B surface antigen by latex agglutination

Publications (2)

Publication Number Publication Date
SE7600797L SE7600797L (sv) 1976-08-20
SE429481B true SE429481B (sv) 1983-09-05

Family

ID=24199232

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7600797A SE429481B (sv) 1975-02-19 1976-01-26 Sett att pavisa hepatit-b-ytantigen genom latexagglutination

Country Status (28)

Country Link
US (1) US3992517A (sv)
JP (1) JPS51106723A (sv)
AR (1) AR210753A1 (sv)
AT (1) AT352290B (sv)
BE (1) BE838474A (sv)
BR (1) BR7600906A (sv)
CH (1) CH613048A5 (sv)
CS (1) CS188129B2 (sv)
DD (1) DD124128A5 (sv)
DE (1) DE2604844C3 (sv)
DK (1) DK144395C (sv)
EG (1) EG12696A (sv)
ES (2) ES445042A1 (sv)
FI (1) FI63493C (sv)
FR (1) FR2301825A1 (sv)
GB (1) GB1529891A (sv)
IE (1) IE42031B1 (sv)
IL (1) IL48927A (sv)
IT (1) IT1066096B (sv)
LU (1) LU74348A1 (sv)
MX (1) MX4962E (sv)
NL (1) NL7601441A (sv)
NZ (1) NZ179988A (sv)
PL (1) PL98604B1 (sv)
RO (1) RO71615A (sv)
SE (1) SE429481B (sv)
SU (1) SU1091844A3 (sv)
ZA (1) ZA76721B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
US4202665A (en) * 1978-11-06 1980-05-13 Albert Einstein College Of Medicine Of Yeshiva University A Division Of Yeshiva University Detection of hepatitis B surface antigen
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
US4310508A (en) * 1979-06-19 1982-01-12 Siber George Diagnostic test and reagent therefor
US4340564A (en) * 1980-07-21 1982-07-20 Daryl Laboratories, Inc. Immunoadsorptive surface coating for solid-phase immunosubstrate and solid-phase immunosubstrate
CA1172561A (en) * 1981-01-28 1984-08-14 Richard H. Decker Igm detection method
US4351824A (en) * 1981-02-05 1982-09-28 Icl Scientific Polystyrene latex reagents, methods of preparation, and use in immunological procedures
US4493899A (en) * 1981-10-16 1985-01-15 City Of Hope Method of testing for particular antibodies in the serum of a patient
FR2531718B1 (fr) * 1982-08-16 1986-11-21 Sanofi Sa Reactif permettant un dosage de tres haute sensibilite de l'antigene caracteristique du virus de l'hepatite b dans les liquides biologiques humains
US4542103A (en) * 1982-09-13 1985-09-17 Miles Laboratories Inc. Latex agglutination determination of IgG in neonatals and in colostrum
JPS60256057A (ja) * 1984-06-01 1985-12-17 Dai Ichi Pure Chem Co Ltd 免疫学的測定法
US6881536B1 (en) * 1986-04-30 2005-04-19 Bioveris Corporation Particle based electrochemiluminescent assays
EP0737863A4 (en) * 1993-12-28 1998-09-30 Ss Pharmaceutical Co METHOD FOR DETECTING BLOOD COMPONENTS AND KIT THEREFOR
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
JP3840521B2 (ja) * 1995-08-21 2006-11-01 Ａｓｐｉｏｎ株式会社 ウイルス検出方法およびウイルス検査用キット

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759948A (fr) * 1969-12-08 1971-06-07 Mc Culler James F Procede de detection de l'hepatite infectieuse et sereuse et reactifs utilises a cet effet
BE787014A (fr) * 1971-07-31 1973-01-31 Pfizer Procede et reactif pour deceler la presence de l'antigene australien
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
JPS49126818A (sv) * 1973-04-13 1974-12-04

Also Published As

Publication number Publication date
FR2301825B1 (sv) 1978-12-15
AT352290B (de) 1979-09-10
DE2604844B2 (de) 1978-01-26
ZA76721B (en) 1977-01-26
JPS51106723A (sv) 1976-09-21
DK60876A (da) 1976-08-20
US3992517A (en) 1976-11-16
AU1100776A (en) 1977-08-18
CH613048A5 (sv) 1979-08-31
DD124128A5 (sv) 1977-02-02
DK144395B (da) 1982-03-01
IT1066096B (it) 1985-03-04
DK144395C (da) 1982-08-02
BE838474A (fr) 1976-08-12
SE7600797L (sv) 1976-08-20
SU1091844A3 (ru) 1984-05-07
NL7601441A (nl) 1976-08-23
IL48927A (en) 1978-12-17
NZ179988A (en) 1978-06-02
IE42031B1 (en) 1980-05-21
FR2301825A1 (fr) 1976-09-17
FI760326A (sv) 1976-08-20
LU74348A1 (sv) 1976-12-31
IL48927A0 (en) 1976-03-31
ATA91776A (de) 1979-02-15
DE2604844A1 (de) 1976-09-02
RO71615A (ro) 1982-08-17
BR7600906A (pt) 1976-10-12
MX4962E (es) 1983-01-20
EG12696A (en) 1979-06-30
DE2604844C3 (de) 1978-09-21
PL98604B1 (pl) 1978-05-31
GB1529891A (en) 1978-10-25
AR210753A1 (es) 1977-09-15
ES451061A1 (es) 1977-09-16
FI63493C (fi) 1983-06-10
FI63493B (fi) 1983-02-28
CS188129B2 (en) 1979-02-28
ES445042A1 (es) 1977-10-01

Similar Documents

Publication Publication Date Title
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE433222B (sv) Sett att framstella modifierad polysackarid
SE7613343L (sv) Sett att framstella notande material
SE422077B (sv) Sett att framstella syntesgas
SE7606280L (sv) Sett att framstella etrar
SE7612532L (sv) Sett att framstella grundpalar
SE7607078L (sv) Sett att framstella skumpolykarbamid
SE412818B (sv) Sett att framstella en halvdedarminnesanordning
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE429481B (sv) Sett att pavisa hepatit-b-ytantigen genom latexagglutination
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE425736B (sv) Sett att framstella kromanon-(4)
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE7606484L (sv) Sett att framstella hoghallfasta cementkonglomerat
SE430687B (sv) Sett att framstella hexanitrostilben
SE419440B (sv) Sett att framstella somatostatinanaloger
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE425321B (sv) Sett att reducera vanadinoxider
SE420729B (sv) Sett att framstella substituerade piperazinyliminorifamyciner
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE7713868L (sv) Sett att framstella tegel
SE7607171L (sv) Sett att framstella indolokinoliziner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7600797-0

Effective date: 19870915

Format of ref document f/p: F